IR Release

This document has been prepared in accordance with accounting principles and practices generally accepted in Japan, and translated for reference only from the original Japanese version. The Company gives no warranty with respect to its correctness.

Oct. 24, 2013

Takara Holdings Inc.

Revision of Consolidated Business Results Forecast for the First Half
of the Fiscal Year Ending March 31, 2014

Kyoto, Japan – Takara Holdings announced revisions to the business results forecast for the first half of the fiscal year ending March 31, 2014 (from April 1, 2013, to March 31, 2014) that it released on May 9, 2013, as stated below. These revisions were based on considerations for recent performance trends.

1. Revised figures for the business results forecast for the first half of the fiscal year ending March 31, 2014 (from April 1, 2013, to September 30, 2013)

2. Reason for revision

Net sales are expected to be ¥1,200 million (1.2%) higher than projected by previously released forecasts due to the influences of yen depreciation.
          As for income, gross profit will be in line with previous forecasts, while operating income is projected to be ¥300 million (15.0%) higher than forecasted following lower-than-expected promotion expenses. This, combined with the anticipated improvement in the balance of non-operating items, is expected to result in ordinary income being ¥500 million (25.0%) higher than projected by previously released forecasts. Further, the sale of a portion of the stock held by the Company in a consolidated subsidiary (Takara Bio Inc.) announced on September 12, 2013, resulted in the recording of gain on sales of subsidiaries and affiliates’ stocks of ¥9.2 billion on a consolidated basis. For this reason, net income is projected to be ¥5,750 million (676.5%) higher than forecasted.

Further, consolidated subsidiary Takara Bio Inc. (Tokyo Stock Exchange Mothers, securities code number: 4974), which conducts the Biomedical business, also announced revisions to forecasts for the six-month period ended September 30, 2013.

3. Full-year business results forecast for the fiscal year ending March 31, 2014

The Company is currently evaluating whether or not revisions to forecasts for consolidated business results for the full fiscal year are necessary and the considering the details of possible revisions. The Company will make an announcement in this regard when it announces its business results for the first half on November 1, 2013.The Company is currently evaluating whether or not revisions to forecasts for consolidated business results for the full fiscal year are necessary and the considering the details of possible revisions. The Company will make an announcement in this regard when it announces its business results for the first half on November 1, 2013.


* The above-mentioned forecasts have been prepared based on the information available as of the date of announcement of this document and could differ from the business result figures scheduled to be announced on November 1, 2013.